These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28864357)

  • 1. Biorelevant Drug Solubility Enhancement Modeled by a Linear Solvation Energy Relationship.
    Niederquell A; Kuentz M
    J Pharm Sci; 2018 Jan; 107(1):503-506. PubMed ID: 28864357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3.
    Fuchs A; Leigh M; Kloefer B; Dressman JB
    Eur J Pharm Biopharm; 2015 Aug; 94():229-40. PubMed ID: 26032292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media.
    Fagerberg JH; Tsinman O; Sun N; Tsinman K; Avdeef A; Bergström CA
    Mol Pharm; 2010 Oct; 7(5):1419-30. PubMed ID: 20507160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of critical micellar concentration for the prediction of solubility enhancement in biorelevant media.
    Ottaviani G; Wendelspiess S; Alvarez-Sánchez R
    Mol Pharm; 2015 Apr; 12(4):1171-9. PubMed ID: 25665011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol effects on apparent solubility of poorly soluble drugs in simulated intestinal fluid.
    Fagerberg JH; Al-Tikriti Y; Ragnarsson G; Bergström CA
    Mol Pharm; 2012 Jul; 9(7):1942-52. PubMed ID: 22651218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
    Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
    Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulating fasted human intestinal fluids: understanding the roles of lecithin and bile acids.
    Söderlind E; Karlsson E; Carlsson A; Kong R; Lenz A; Lindborg S; Sheng JJ
    Mol Pharm; 2010 Oct; 7(5):1498-507. PubMed ID: 20698569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution behavior of various drugs in different FaSSIF versions.
    Klumpp L; Leigh M; Dressman J
    Eur J Pharm Sci; 2020 Jan; 142():105138. PubMed ID: 31704344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
    Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs.
    Zhou Z; Dunn C; Khadra I; Wilson CG; Halbert GW
    Eur J Pharm Sci; 2017 Mar; 99():95-104. PubMed ID: 27940083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal solubility and absorption of poorly water soluble compounds: predictions, challenges and solutions.
    Fagerberg JH; Bergström CA
    Ther Deliv; 2015; 6(8):935-59. PubMed ID: 26316058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids.
    Clarysse S; Brouwers J; Tack J; Annaert P; Augustijns P
    Eur J Pharm Sci; 2011 Jul; 43(4):260-9. PubMed ID: 21570465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization from Supersaturated Solutions: Role of Lecithin and Composite Simulated Intestinal Fluid.
    Indulkar AS; Gao Y; Raina SA; Zhang GGZ; Taylor LS
    Pharm Res; 2018 Jun; 35(8):158. PubMed ID: 29916053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasted-state simulated intestinal fluid "FaSSIF-C", a cholesterol containing intestinal model medium for in vitro drug delivery development.
    Khoshakhlagh P; Johnson R; Langguth P; Nawroth T; Schmueser L; Hellmann N; Decker H; Szekely NK
    J Pharm Sci; 2015 Jul; 104(7):2213-24. PubMed ID: 25964103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating pediatric and adult simulated fluids solubility: Abraham solvation parameters and multivariate analysis.
    Guimarães M; Kuentz M; Vertzoni M; Fotaki N
    Pharm Res; 2021 Nov; 38(11):1889-1896. PubMed ID: 34697725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design.
    Zhou Z; Dunn C; Khadra I; Wilson CG; Halbert GW
    Mol Pharm; 2017 Dec; 14(12):4132-4144. PubMed ID: 28749696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The dissolution test in biorelevant media as a prognostic tool for modeling of drug behavior in vivo].
    Ramenskaia GV; Shokhin IE; Savchenko AIu; Volkova EA
    Biomed Khim; 2011; 57(5):482-9. PubMed ID: 22629598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of solubilising effects of bile salts on an active pharmaceutical ingredient with unusual pH dependent solubility by NMR spectroscopy.
    Vogtherr M; Marx A; Mieden AC; Saal C
    Eur J Pharm Biopharm; 2015 May; 92():32-41. PubMed ID: 25720817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs.
    Khadra I; Zhou Z; Dunn C; Wilson CG; Halbert G
    Eur J Pharm Sci; 2015 Jan; 67():65-75. PubMed ID: 25444845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid.
    McPherson S; Perrier J; Dunn C; Khadra I; Davidson S; Ainousah B; Wilson CG; Halbert G
    Eur J Pharm Biopharm; 2020 May; 150():14-23. PubMed ID: 32035969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.